| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911069 | Lung Cancer | 2015 | 36 Pages |
Abstract
Afatinib demonstrated signs of clinical activity in heavily pretreated patients with activating HER2 or EGFR mutations or EGFR FISH-positive tumors.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jacques De Grève, Teresa Moran, Marie-Pascale Graas, Daniella Galdermans, Peter Vuylsteke, Jean-Luc Canon, Denis Schallier, Lore Decoster, Erik Teugels, Dan Massey, Vikram K. Chand, Johan Vansteenkiste,